Govt caps maximum price of Covishield, Covaxin, Sputnik V for pvt hospitals

The govt has set the maximum price private hospitals can charge for the three Covid vaccines currently available in the country -- Covishield Rs 780 per dose, Covaxin Rs 1,410, and Sputnik V Rs 1,145

Covaxin, Covishield, serum institute of india, bharat biotech, vaccine, vaccination, coronavirus, covid
The Health Ministry asked states to ensure that the prices declared by various private CVCs do not exceed the ceiling
Press Trust of India New Delhi
2 min read Last Updated : Jun 08 2021 | 10:49 PM IST

The government has set the maximum price private hospitals can charge for the three Covid-19 vaccines currently available in the country -- Covishield Rs 780 per dose, Covaxin Rs 1,410 and Sputnik V Rs 1,145.

In a letter to all states and union territories on Tuesday, the Health Ministry suggested that appropriate strict action be taken against private vaccination centres for overcharging.

The maximum price of Covishield for private Covid-19 Vaccination Centres (CVCs) has been fixed at Rs 780 per dose, while that of Covaxin is Rs 1,410 per dose and Sputnik V Rs 1,145 per dose, it said.

The Health Ministry asked states to ensure that the prices declared by various private CVCs do not exceed the ceiling.

"The private hospitals may charge up to a maximum of Rupees 150 per dose as service charges. State governments may monitor the price being so charged," the ministry said.

The ministry also requested states and union territories to regularly monitor the prices being charged by the private CVCs from the citizens.

"It is also requested that wherever instances of overcharging as compared to the price declared by the CVC come to notice, appropriate strict action is taken against any such private CVCs," it said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineVaccinationVaccineBharat BiotechAstraZenecaSerum Institute of IndiaPrivate hospitalsRussia

First Published: Jun 08 2021 | 10:29 PM IST

Next Story